Skip to main content
. Author manuscript; available in PMC: 2017 Jan 9.
Published in final edited form as: Acta Biomed. 2010;81(Suppl 1):19–29.

Figure 1.

Figure 1

Overview of the hypothesized molecular, physiological, and clinical pathway to frailty focusing on the potential interaction between gene variation, oxidative stress and neuroendocrine dysregulation in the development of frailty (Adapted from Ref 9)